Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways

Kris Genelyn Dimasuay, Amelia Sanchez, Niccolette Schaefer, Jorge Polanco, Deborah A Ferrington, Hong Wei Chu

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Rhinovirus (RV) infection is involved in acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). RV primarily infects upper and lower airway epithelium. Immunoproteasomes (IP) are proteolytic machineries with multiple functions including the regulation of MHC class I antigen processing during viral infection. However, the role of IP in RV infection has not been explored. We sought to investigate the expression and function of IP during airway RV infection. Primary human tracheobronchial epithelial (HTBE) cells were cultured at air-liquid interface (ALI) and treated with RV16, RV1B, or interferon (IFN)-λ in the absence or presence of an IP inhibitor (ONX-0914). IP gene (i.e. LMP2) deficient mouse tracheal epithelial cells (mTECs) were cultured for the mechanistic studies. LMP2-deficient mouse model was used to define the in vivo role of IP in RV infection. IP subunits LMP2 and LMP7, antiviral genes MX1 and OAS1 and viral load were measured. Both RV16 and RV1B significantly increased the expression of LMP2 and LMP7 mRNA and proteins, and IFN-λ mRNA in HTBE cells. ONX-0914 down-regulated MX1 and OAS1, and increased RV16 load in HTBE cells. LMP2-deficient mTECs showed a significant increase in RV1B load compared with the wild-type (WT) cells. LMP2-deficient (compared with WT) mice increased viral load and neutrophils in bronchoalveolar lavage (BAL) fluid after 24 h of RV1B infection. Mechanistically, IFN-λ induction by RV infection contributed to LMP2 and LMP7 up-regulation in HTBE cells. Our data suggest that IP are induced during airway RV infection, which in turn may serve as an antiviral and anti-inflammatory mechanism.

Original languageEnglish (US)
Pages (from-to)1711-1723
Number of pages13
JournalClinical science
Issue number15
StatePublished - Aug 1 2018

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health [grant numbers R01 HL122321, R01 AI106287, R01 HL125128, U19 AI125357].

Publisher Copyright:
© 2018 The Author(s).


Dive into the research topics of 'Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways'. Together they form a unique fingerprint.

Cite this